Use of Canagliflozin in Kidney Transplant Recipients for the Treatment of Type 2 Diabetes: A Case Series.

Rajasekeran, Harindra; Kim, S Joseph; Cardella, Carl J; Schiff, Jeffrey; Cattral, Mark; Cherney, David Z I; Singh, Sunita K S

Rajasekeran, Harindra; Kim, S Joseph; Cardella, Carl J; Schiff, Jeffrey; Cattral, Mark; Cherney, David Z I; Singh, Sunita K S.

Afiliação

Rajasekeran H; Division of Nephrology, Department of Medicine, University of Toronto, Toronto, Canada.
Kim SJ; Department of Physiology, University of Toronto, Toronto, Canada.
Cardella CJ; Division of Nephrology, Department of Medicine, University of Toronto, Toronto, Canada.
Schiff J; Kidney Transplant Program, Toronto General Hospital, University Health Network, Toronto, Canada.
Cattral M; Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Canada.
Cherney DZI; Division of Nephrology, Department of Medicine, University of Toronto, Toronto, Canada.
Singh SKS; Kidney Transplant Program, Toronto General Hospital, University Health Network, Toronto, Canada.

Diabetes Care ; 40(7): e75-e76, 2017 07.

Article em En | MEDLINE | ID: mdl-28416475

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Idioma: En Revista: Diabetes Care Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Canadá